Edward Kavalerchik, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy
Dr. Edward Kavalerchik graduated the medical school from the Stony Brook University School of Medicine and soon after that he completed both his residency and fellowship program at the University of California San Diego. He is specialized in oncology and board certified in medical oncology. Dr. Kavalerchik has been in practice for more than 11 years and is affiliated with the La Jolla Office. During his career, he has also contributed to five publications of medical interest.
Stony Brook University
Medical School
University of California San Diego
Residency
University of California San Diego
Fellowship
American Board of Internal Medicine - Oncology
Serum free light chain reduction correlates with response and progression-free survival following carfilzomib therapy in relapsed/refractory multiple myeloma.
Vij R, Wang M, Jagannath S, Niesvizky R, Jakubowiak AJ, Kavalerchik E, Huang M, Siegel DS; Leuk Lymphoma. 2015.
See more >>Phase 2 dose-expansion study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myeloma.
Wang M, Martin T, Bensinger W, Alsina M, Siegel DS, Kavalerchik E, Huang M, Orlowski RZ, Niesvizky R; Blood. 2013 Oct 31.
See more >>Chronic myeloid leukemia stem cells.
Kavalerchik E, Goff D, Jamieson CH; J Clin Oncol. 2008 Jun 10.
See more >>American Society of Clinical Oncology
American Society of Hematology